Finland· FI-REL-REL1628
Lomudal Nasal
A cromoglicic acid product containing sodium cromoglicate, registered in Finland by Aventis Pharma Le Trait. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Cromoglicic acid is registered in 5 of 19 countries.
Countries holding a registration under ATC R01AC01 (cromoglicic acid), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Cromoglicic acid · ATC R01AC01
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Netherlands
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Sodium cromoglicate
- Manufacturer
- Aventis Pharma Le Trait
- Country
- Finland (FI)
- ATC code
- R01AC01
- ATC class
- Cromoglicic acid
- Defined daily dose
- 40 mg, N
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cromoglicic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAllercrom 2% eye dropsViatris UK Healthcare Ltd
- NetherlandsAllerg-Abak 20 mg/ml, oogdruppels, oplossingLaboratoires Théa
- GermanyAllergovalKoehler Pharma Gmbh
- United Statescromolyn sodiumMylan Pharmaceuticals Inc.
- FranceALAIRGIX RHINITE ALLERGIQUE CROMOGLICATE DE SODIUM 2 %, solution pour pulvérisation nasaleCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- NorwayAllergovalKöhler Pharma
- BelgiumAlleophta Unidosis 20 mg/mlOpella Healthcare Belgium
- SwedenAllgil 20 mg/ml Ögondroppar, lösningEvolan Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Allergo-Comod, Allergocrom
- Belgium · Allergo-Comod, Cromabak
- Bulgaria · Lecrolyn Sine
- Cyprus · Cromodal, Vividrin
- Czechia · Allergo-Comod, Allergocrom
- Germany · Allergoval, Cromo
- Denmark · Lecrolyn Sine, Lomudal
- Estonia · Lecrolyn, Lecrolyn Sine
- Spain · Gastrofrenal
- France · Alairgix Rhinite Allergique, Allergocomod
- United Kingdom (Northern Ireland) · Alleopti Allergy, Alleopti Hayfever
- Greece · Allergotin, Chromoprol
- Hungary · Lecrolyn, Taleum
- Ireland · Opticrom, Opticrom Allergy
- Iceland · Lecrolyn Sine, Lomudal
- Italy · Brunicrom, Lecrosine
- Lithuania · Lecrolyn, Lecrolyn Sine
- Luxembourg · Allergo-Comod, Cromabak
- Latvia · Lecrolyn Sine
- Malta · Allergo-Comod, Allergotin
- Netherlands · Allerg-Abak, Allergieneusspray Natriumcromoglicaat Etos
- Norway · Lecrolyn Sine, Lomudal
- Poland · Allergo-Comod, Allergocrom
- Portugal · Allergocrom, Cromabak
- Romania · Alergorom, Lecrolyn
- Sweden · Allgil, Lecrolyn
- Slovakia · Allergocrom, Lecrolyn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bacbc5c3-e4f0-4d10-a95f-807160abaf78 GET /v1/drugs/bacbc5c3-e4f0-4d10-a95f-807160abaf78?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "40",
"form": "nenäsumute",
"route": null,
"ddd_unit": "mg",
"strength": "2.6 mg/annos",
"atc_label": "natriumkromoglikaatti",
"ma_number": "11372",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL1628",
"authorised_at": "1994-02-07"
}See everything about cromoglicic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.